Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Paracorporeal lung assist device: an innovative surgical strategy for bridging to lung transplant in an infant with severe pulmonary hypertension caused by alveolar capillary dysplasia.

Boston US, Fehr J, Gazit AZ, Eghtesady P.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):e42-3. doi: 10.1016/j.jtcvs.2013.06.014. Epub 2013 Jul 18. No abstract available.

2.

Paracorporeal lung assist devices as a bridge to recovery or lung transplantation in neonates and young children.

Hoganson DM, Gazit AZ, Boston US, Sweet SC, Grady RM, Huddleston CB, Eghtesady P.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):420-6. doi: 10.1016/j.jtcvs.2013.08.078. Epub 2013 Nov 4.

3.

Alveolar capillary dysplasia presenting as pneumothorax: a case report and review of literature.

Roy PG, Patel P, Vayalakkad A, Bowker C, Lakhoo K.

Pediatr Surg Int. 2007 Sep;23(9):915-7.

PMID:
17394004
4.

The management of neonatal pulmonary hypertension.

Dhillon R.

Arch Dis Child Fetal Neonatal Ed. 2012 May;97(3):F223-8. doi: 10.1136/adc.2009.180091. Epub 2011 Jan 30. Review.

PMID:
21278430
5.
6.

Neonatal paracorporeal lung assist device for respiratory failure.

Hoganson DM, Gazit AZ, Sweet SC, Grady RM, Huddleston CB, Eghtesady P.

Ann Thorac Surg. 2013 Feb;95(2):692-4. doi: 10.1016/j.athoracsur.2012.05.128.

PMID:
23336880
7.

Alveolar capillary dysplasia: a cause of persistent pulmonary hypertension of the newborn.

Alameh J, Bachiri A, Devisme L, Truffert P, Rakza T, Riou Y, Manouvrier S, Lequien P, Storme L.

Eur J Pediatr. 2002 May;161(5):262-6. Epub 2002 Mar 23.

PMID:
12012221
8.

[The treatment of severe pulmonary hypertension in newborn infants using extracorporeal membrane oxygenation or conventional measures. An interinstitutional comparison].

Möller JC, Jonas S, Sussmane JB, Tegtmeyer FK, Vardag AM, Richter A.

Monatsschr Kinderheilkd. 1991 Oct;139(10):681-6. German.

PMID:
1961206
9.

Extracorporeal membrane oxygenation in pulmonary crisis and primary graft dysfunction.

Hsu HH, Ko WJ, Chen JS, Lin CH, Kuo SW, Huang SC, Lee YC.

J Heart Lung Transplant. 2008 Feb;27(2):233-7. doi: 10.1016/j.healun.2007.11.570.

PMID:
18267233
10.

Pulmonary arterial hypertension in the pediatric age.

Donti A, Formigari R, Ragni L, Manes A, Galiè N, Picchio FM.

J Cardiovasc Med (Hagerstown). 2007 Jan;8(1):72-7. Review.

PMID:
17255821
11.

Persistent pulmonary hypertension of the newborn. The black box revisited.

Walsh-Sukys MC.

Clin Perinatol. 1993 Mar;20(1):127-43. Review.

PMID:
8458161
12.

Persistent pulmonary hypertension of the newborn.

Peters EA, Engle WA, Lemons JA.

Indiana Med. 1989 Jan;82(1):13-7. No abstract available.

PMID:
2921513
13.

Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.

Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R, Thébaud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M, Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G, Humpl T, Wessel DL; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; and the American Thoracic Society.

Circulation. 2015 Nov 24;132(21):2037-99. doi: 10.1161/CIR.0000000000000329. Epub 2015 Nov 3. Erratum in: Circulation. 2016 Jan 26;133(4):e368.

14.

Recommendations for utilization of the paracorporeal lung assist device in neonates and young children with pulmonary hypertension.

Gazit AZ, Sweet SC, Grady RM, Boston US, Huddleston CB, Hoganson DM, Shepard M, Raithel S, Mehegan M, Doctor A, Spinella PC, Eghtesady P.

Pediatr Transplant. 2016 Mar;20(2):256-70. doi: 10.1111/petr.12673. Epub 2016 Feb 21.

PMID:
26899454
15.

Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology.

Walsh MC, Stork EK.

Clin Perinatol. 2001 Sep;28(3):609-27, vii. Review.

PMID:
11570157
16.

Pathophysiology of persistent pulmonary hypertension of the newborn: impact of the perinatal environment.

Storme L, Aubry E, Rakza T, Houeijeh A, Debarge V, Tourneux P, Deruelle P, Pennaforte T; French Congenital Diaphragmatic Hernia Study Group.

Arch Cardiovasc Dis. 2013 Mar;106(3):169-77. doi: 10.1016/j.acvd.2012.12.005. Epub 2013 Mar 29. Review.

17.

Outcomes of neonates requiring extracorporeal membrane oxygenation for irreversible pulmonary dysplasia: the Extracorporeal Life Support Registry experience.

Lazar DA, Olutoye OO, Cass DL, Fernandes CJ, Welty SE, Johnson KE, Rycus PT, Lee TC.

Pediatr Crit Care Med. 2012 Mar;13(2):188-90. doi: 10.1097/PCC.0b013e3182231060.

PMID:
21666536
18.

Alveolar capillary dysplasia--a cause of persistent pulmonary hypertension unresponsive to a second course of extracorporeal membrane oxygenation.

Chelliah BP, Brown D, Cohen M, Talleyrand AJ, Shen-Schwarz S.

Pediatrics. 1995 Dec;96(6):1159-61. Review. No abstract available.

PMID:
7491243
19.

Alveolar capillary dysplasia: diagnostic potential for cardiac catheterization.

Hintz SR, Vincent JA, Pitlick PT, Fineman JR, Steinhorn RH, Kim GE, Benitz WE.

J Perinatol. 1999 Sep;19(6 Pt 1):441-6.

PMID:
10685275
20.

Omphalocele and alveolar capillary dysplasia: a new association.

Gerrits LC, De Mol AC, Bulten J, Van der Staak FH, Van Heijst AF.

Pediatr Crit Care Med. 2010 May;11(3):e36-7. doi: 10.1097/PCC.0b013e3181b80a75.

PMID:
20453609

Supplemental Content

Support Center